Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect

Hum Genet. 1995 May;95(5):551-6. doi: 10.1007/BF00223868.


We identified a germline missense mutation at nucleotide 505 (T to C) of the VHL tumor suppressor gene in 14, apparently unrelated, VHL type 2A families from the Black Forest region of Germany. This mutation was previously identified in two VHL 2A families living in Pennsylvania (USA). All affected individuals in the 16 families shared the same VHL haplotype indicating a founder effect. This missense mutation at codon 169 (Tyr to His) would probably cause an alteration in the structure of the putative VHL protein. The association of this distinct mutation with the pheochromocytoma phenotype in VHL may help to elucidate the genetic mechanism of carcinogenesis in this multi tumor cancer syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Gland Neoplasms / complications
  • Adrenal Gland Neoplasms / genetics*
  • Alleles
  • Base Sequence
  • DNA Mutational Analysis
  • DNA Primers / chemistry
  • Electrophoresis, Agar Gel
  • Female
  • Founder Effect*
  • Genes, Tumor Suppressor / genetics
  • Germ-Line Mutation
  • Germany
  • Haplotypes
  • Humans
  • Male
  • Molecular Sequence Data
  • Pedigree
  • Pennsylvania
  • Pheochromocytoma / complications
  • Pheochromocytoma / genetics*
  • Point Mutation*
  • Polymerase Chain Reaction
  • von Hippel-Lindau Disease / complications
  • von Hippel-Lindau Disease / genetics*


  • DNA Primers